ST-115
Modify Date: 2024-01-14 22:24:35
ST-115 structure
|
Common Name | ST-115 | ||
|---|---|---|---|---|
| CAS Number | 1840873-90-6 | Molecular Weight | 457.561 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H32FN3O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ST-115ST-115 (ST115) is a potent and specific inhibitor of aminopeptidase P2 (XPNPEP2, APP2) with IC50 of 3.7 nM.ST-115 does not inhibit ACE, neprilysin, or multiple other enzymes, and littile inhibition against Aminopeptidase P1/A/B/N (IC50=600 nM->10 uM).ST-115 can reduce bradykinin degradation, increasing its concentration and protective effects when administered intravenously at the start of reperfusion, reduced damaged area of the heart in a mouse model of myocardial infarction.In a rat model of ischemic stroke, ST-115 reduced functional deficits in a skilled walking test by 60% and reduced brain edema by 51%.ST-115 also reduced brain infarct size by 48% in a major subset of rats with small strokes. |
| Name | ST-115 |
|---|
| Description | ST-115 (ST115) is a potent and specific inhibitor of aminopeptidase P2 (XPNPEP2, APP2) with IC50 of 3.7 nM.ST-115 does not inhibit ACE, neprilysin, or multiple other enzymes, and littile inhibition against Aminopeptidase P1/A/B/N (IC50=600 nM->10 uM).ST-115 can reduce bradykinin degradation, increasing its concentration and protective effects when administered intravenously at the start of reperfusion, reduced damaged area of the heart in a mouse model of myocardial infarction.In a rat model of ischemic stroke, ST-115 reduced functional deficits in a skilled walking test by 60% and reduced brain edema by 51%.ST-115 also reduced brain infarct size by 48% in a major subset of rats with small strokes. |
|---|---|
| References | 1. Morgan Rae Lenz, et al. J Pharmacol Exp Ther. 2022 Jan 3;JPET-AR-2021-000875. |
| Molecular Formula | C21H32FN3O5S |
|---|---|
| Molecular Weight | 457.561 |